Pharmadrug Appoints Cannabis Icon Terry Booth as Chairman of Advisory Board
Ryan Allway June 3rd, 2020 News, Psychedelics Toronto, Ontario–(Newsfile Corp. – June 2, 2020) – PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the “Company” or “PharmaDrug“) is pleased to announce that it has appointed global cannabis industry pioneer and founder of Aurora Cannabis Inc. (NYSE: ACB) (“Aurora“), Terry Booth, as the Chairman... Read more
Red Light Holland Appoints Prominent Real Estate Developer, Brad J. Lamb, as Chairman of the Board of Directors and Provides Corporate Update
Toronto, Ontario–(Newsfile Corp. – June 2, 2020) – Red Light Holland Corp. (CSE:TRIP) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased... Read more
VANCOUVER, British Columbia, June 1, 2020 /CNW/ — NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) (“NewLeaf Brands” or the “Company“) is pleased to announce that it has changed its name from NewLeaf Brands Inc. to Mydecine Innovations Group Inc. and its ticker symbol from ‘NLB’ to ‘MYCO’. Subject to approval of the... Read more
Pharmadrug Inc. Unveils Roadmap for European Psilocybin Business
Ryan Allway May 29th, 2020 News, Psychedelics, Top News Toronto, Ontario–(Newsfile Corp. – May 29, 2020) – Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (“PharmaDrug” or the “Company”) has released an overview of their plans to enter the European psilocybin marketplace via the pending closing of the acquisition of Interrobang LTD.... Read more
MindMed Adds MDMA to Develop Next-Gen Psychedelic Therapies
NEW YORK, May 27, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, is now adding the psychedelic compound MDMA to its R&D pipeline. The latest development comes as part of MindMed’s exclusive license and collaboration agreement with the University Hospital Basel’s... Read more
NewLeaf Brands Agrees to Acquire Mindleap Health Inc., Digital Health Platform to Combine Mood, Emotion and Habit Tracking With Tele-health in the Fight Against Mental Illness
Ryan Allway May 21st, 2020 Psychedelics NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) (“NewLeaf Brands” or the “Company”) is pleased to announce that it has signed a non-binding Letter of Intent (“LOI”) with Mindleap Health Inc. (“Mindleap”), dated May 20, 2020, pursuant to which NewLeaf Brands will... Read more
Psychedelics Company, Numinus, To Begin Trading May 20th
Ryan Allway May 18th, 2020 Psychedelics Numinus Wellness Inc. (formerly Rojo Resources Ltd., RJ:H) (“Numinus” or the “Company“) (TSXV: NUMI) is pleased to announce that it has closed its previously announced reverse take-over transaction with Salvation Botanicals Ltd. (“Salvation“) and has acquired all of the outstanding securities of Salvation... Read more
Mota Looks to Enter into Psychedelics with Binding Term Sheet
Ryan Allway May 18th, 2020 Psychedelics Mota Ventures Corp. (CSE:MOTA FSE: 1WZ:GR OTC: PEMTF) (the “Company”) announces that it has entered into a binding term sheet (the Term Sheet”), dated May 14, 2020, with Verrian Ontario Limited (“Verrian”), pursuant to which it proposes to acquire all of the outstanding... Read more
Champignon Expands to U.S., To Acquire California Based Ketamine Centre – Wellness Clinic of Orange County
Ryan Allway May 14th, 2020 Psychedelics Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences Company with an emphasis on ketamine and psychedelic medicine is pleased to announce that it has executed a term sheet (the “Term Sheet”) with California, U.S.... Read more
NeonMind Completes Design of Preclinical Psilocybin Psychedelic Mushroom Study
Ryan Allway May 14th, 2020 News, Psychedelics Vancouver, British Columbia–(Newsfile Corp. – May 14, 2020) – The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces its majority owned subsidiary NeonMind has completed the design of a preclinical study to confirm that psilocybin (found in psychedelic mushrooms) is an effective... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )